Latest news
-
-
October 11, 2018
Almac Group Invests in Cutting Edge Next Generation Sequencing Capabilities for Bio Pharma Clients
-
October 10, 2018
Almac Group Invests to Expand its Existing North Carolina Facility
-
April 16, 2018
Almac Diagnostic Services Validates Illumina TruSight® Tumor 170 Cancer Mutation Panel for Prospective Testing in Clinical Trials
-
February 12, 2018
Almac Diagnostic Services Partners with DNAnexus to Power Clinical Trial Assay Development
-
October 23, 2017
Queen’s University Belfast in Collaboration with Almac Group Lead Largest Study of its Kind to Transform Prostate Cancer Treatment
-
June 13, 2017
Almac Group Awarded U.S. Patents for Ground-breaking “DDRD” Assay
-
April 20, 2017
Almac Group Announces Publication of Prostate Cancer Metastatic Assay Validation
-
March 8, 2017
Almac Diagnostic Services and EORTC Establish Collaboration for Tumour Molecular Profiling